On the basis of the MM-009 and MM-010 trials, lenalidomide in combination with dexamethasone has been approved by the US Food and Drug Administration and European Medicines Agency for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback